- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03263455
Kinesio-Taping in Stroke Patients With Visuospatial Neglect (k-neglect)
August 25, 2017 updated by: Nicola Smania, MD, Clinical Professor, Universita di Verona
The Effects of Kinesis-Taping Application on Cognitive Deficit and Motor Ability in Stroke Patients With Visuospatial Neglect: a Randomized Controlled Study
Stroke is the second leading cause of death worldwide and the third most common cause of disability.
The effects of stroke are variable and may include impairments in motor and sensory systems, emotion and neuropsychological deficits such as a disorder of spatial awareness known as unilateral spatial neglect (USN).
Approaches to ameliorate USN could be categorized in interventions as involving either bottom-up or top-down processing.
The specific mechanisms underlying these effects on a number of manifestations of the USN syndrome may include the restoration of defective representations of the side of space contralateral to the lesion (contralesional), and of the ability to orient spatial attention contralesionally, through complex patterns of activation of both the damaged right hemisphere, and the contralateral left hemisphere, with differences related to the specific stimulation delivered to the patient.
In recent years, increasing cutaneous stimuli through neuromuscular kinesiotaping has been proposed to enhance somatosensory inputs (24) and such as method could have positive effects on USN.
The aim of the present study was to assess the effect of KTM applied on the sternocleidomastoid muscle controlateral side of the lesions in improving USN deficits in individuals with stroke patient in sub-acute phase.
The hypothesis is that the KTM application could improved cognitive tests for assessing USN, motor deficits and kinesthetic neck sensibility.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Valentina Varalta, PS
- Phone Number: 00390458124950
- Email: valentina.varalta@univr.it
Study Contact Backup
- Name: Daniele Munari, PT
- Phone Number: 00390458124950
- Email: daniele.munari@univr.it
Study Locations
-
-
-
Verona, Italy, 37134
- Azienta Ospedaliera, SSO Rehabilitation Unit, Verona
-
-
Italy, Verona
-
Verona, Italy, Verona, Italy, 37134
- Azienta Ospedaliera, SSO Rehabilitation Unit, Verona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients affected by stroke from cerebral ischemia or hemorrhage that occurred ⩽ 30 days before;
- presence of visuospatial neglect (Star Cancellation Test' score < 50)
- able to actively rotate the head toward left side in closed eyes condition.
Exclusion Criteria:
- the presence of dementia (Mini-Mental State Examination correct score lower than 23,80)
- severe deficit of comprehension
- psychiatric disorders
- hemianopsia patients (diagnosed with perimetry) patients or their family members did not consent to this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kinesio Taping group
The tape in the KT group was applied with paper-off tension, which means applying the tape directly to the skin as it comes off the paper backing (approximately with 15% to 25% of available tension).
|
The tape in the KT group will be applied with paper-off tension, which means applying the tape directly to the skin as it comes off the paper backing (approximately with 15% to 25% of available tension).
KinesioTape will be applied over the SCM dystonic muscle by means of 2 "I-strips": the first strip will be placed on the medial (sternal) head and the second will be applied on the lateral (clavicular) head of the SCM muscle.
KinesioTape was applied from the mastoid bone to the clavicle (rostrocaudal direction) with the SCM placed in a position of maximum stretching.
|
Sham Comparator: Sham Taping group
Patients in the ST group, smaller "I-strips" of KinesioTape were used and they were applied, with no tension and without stretching the muscles, perpendicularly to the muscle belly (starting from the middle and progressing to each side) over the same dystonic muscles as in the Kinesio Taping group
|
Patients in the ST group, smaller "I-strips" of KinesioTape will be used and they will be applied, with no tension and without stretching the muscles, perpendicularly to the muscle belly (starting from the middle and progressing to each side) over the same dystonic muscles as in the experimental group.
Although the specific therapeutic elements of KinesioTaping (ie, longitudinal stretch, start and ending point tape application) will be removed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The Stars Cancellation Test change in number of stars deleted
Time Frame: Baseline time 0 and up to 4 weeks
|
Baseline time 0 and up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of letter delete during the Letter Cancellation Test
Time Frame: Baseline time 0 and up to 4 weeks
|
Baseline time 0 and up to 4 weeks
|
Number of Error assessed during the Cervical Joint Position Error Test
Time Frame: Baseline time 0 and up to 4 weeks
|
Baseline time 0 and up to 4 weeks
|
Degree of Active Range of Motion (AROM) during left rotation
Time Frame: Baseline time 0 and up to 4 weeks
|
Baseline time 0 and up to 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicola Smania, MD, Neuromotor and Cognitive Rehabilitation Center Department for Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy P.zza L.A. Scuro, 10 37134 Verona, Italia
- Study Director: Alessandro Picelli, MD, Neuromotor and Cognitive Rehabilitation Center Department for Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy P.zza L.A. Scuro, 10 37134 Verona, Italia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2017
Primary Completion (Anticipated)
November 30, 2017
Study Completion (Anticipated)
August 1, 2018
Study Registration Dates
First Submitted
August 14, 2017
First Submitted That Met QC Criteria
August 25, 2017
First Posted (Actual)
August 28, 2017
Study Record Updates
Last Update Posted (Actual)
August 28, 2017
Last Update Submitted That Met QC Criteria
August 25, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KN2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Kinesio taping group
-
Yağmur SÜRMELİRecruiting
-
Dokuz Eylul UniversityCompletedSacroiliac Joint DysfunctionTurkey
-
Istanbul Medipol University HospitalNot yet recruitingScapular DyskinesisTurkey
-
Cardenal Herrera UniversityCompletedMobility Limitation | Myofascial Trigger Point PainSpain
-
Cardenal Herrera UniversityCompletedMobility Limitation | Myofascial Trigger Point Pain
-
Ataturk Training and Research HospitalUnknown
-
Norwegian School of Sport SciencesCompletedMuscle Weakness | Anterior Knee Pain | Knee SymptomsNorway
-
Universidade Federal de PernambucoCompleted
-
University of JazanCompletedMeniscus TearSaudi Arabia
-
Çankırı Karatekin UniversityCompletedPostoperative Pain | Gas Bloat Syndrome | Defecation DisordersTurkey